Literature DB >> 16759762

Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

Lisa F Shubitz1, Jieh-Juen Yu, Chiung-Yu Hung, Theo N Kirkland, Tao Peng, Robert Perrill, Julie Simons, Jianmin Xue, Roger A Herr, Garry T Cole, John N Galgiani.   

Abstract

Two recombinant antigens which individually protect mice from lethal intranasal infection were studied in combination, either as a mixture of two separately expressed proteins or as a single chimeric expression product. Mice vaccinated with either combination survived longer than mice given single antigens. Immunized mice also exhibited specific IgG immunoglobulins and yielded splenocytes which produced interferon-gamma in response to either antigen. The chimeric antigen has the practical advantage of offering enhanced protection from multiple components without increasing production costs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759762     DOI: 10.1016/j.vaccine.2006.04.002

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

Review 1.  An insight into the antifungal pipeline: selected new molecules and beyond.

Authors:  Luis Ostrosky-Zeichner; Arturo Casadevall; John N Galgiani; Frank C Odds; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2010-08-20       Impact factor: 84.694

2.  Vaccines to prevent systemic mycoses: holy grails meet translational realities.

Authors:  John N Galgiani
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

3.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

4.  A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.

Authors:  Hema P Narra; Lisa F Shubitz; M Alejandra Mandel; Hien T Trinh; Kurt Griffin; Adam S Buntzman; Jeffrey A Frelinger; John N Galgiani; Marc J Orbach
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

5.  Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.

Authors:  Celine A Hayden; Chiung-Yu Hung; Hao Zhang; Austin Negron; Raymond Esquerra; Gary Ostroff; Ambily Abraham; Alejandro Gabriel Lopez; Juliet Elizabeth Gonzales; John A Howard
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

Review 6.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

7.  Multivalent recombinant protein vaccine against coccidioidomycosis.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

8.  Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Authors:  Roger A Herr; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Authors:  Lisa F Shubitz; Sharon M Dial; Robert Perrill; Rachael Casement; John N Galgiani
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Authors:  Lisa F Shubitz; Hien T Trinh; Robert H Perrill; C Michael Thompson; Nathan J Hanan; John N Galgiani; David E Nix
Journal:  J Infect Dis       Date:  2014-01-12       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.